PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10678088-6	1999	CCK-A receptor antagonist devazepide (10 nmol.L-1) reversed the antagonism of sincalide to the effect of morphine.	Sincalide	78-87	cholecystokinin A receptor	Rattus norvegicus	0-14	
14715522-9	2004	The CCK(A) receptor antagonist devazepide (500 microg/kg intravenous) inhibited motion responses evoked by intravenous CCK-8.	Sincalide	119-124	cholecystokinin A receptor	Rattus norvegicus	4-19	
10678088-8	1999	The antagonistic effect of sincalide on morphine was mainly mediated by CCK-A receptor.	Sincalide	27-36	cholecystokinin A receptor	Rattus norvegicus	72-86	
11324560-3	1998	The CCK-8 effect, again, could be suppressed by CCK-A receptor antagonist devazepide (10 nmol/L), but partially by CCK-B receptor antagonist L-365, 260 at 10 nmol/L or completely at concentration of 30 nmol/L.	Sincalide	4-9	cholecystokinin A receptor	Rattus norvegicus	48-62	
11819361-4	1998	On the basis of the above, CCK-A receptor antagonist Devazepide could reverse the antagonism of CCK-8 to the effect of morphine.CONCLUSION:CCK-8 could antagonize the effect of morphine which inhibited the potentiation of ACh on the duodenal activities in vitro.Furthermore, it was inferred that the antagonistic effect of CCK-8 on morphine was mainly mediated by CCK-A receptor.	Sincalide	96-101	cholecystokinin A receptor	Rattus norvegicus	27-41	
11819361-4	1998	On the basis of the above, CCK-A receptor antagonist Devazepide could reverse the antagonism of CCK-8 to the effect of morphine.CONCLUSION:CCK-8 could antagonize the effect of morphine which inhibited the potentiation of ACh on the duodenal activities in vitro.Furthermore, it was inferred that the antagonistic effect of CCK-8 on morphine was mainly mediated by CCK-A receptor.	Sincalide	96-101	cholecystokinin A receptor	Rattus norvegicus	363-377	
11819361-4	1998	On the basis of the above, CCK-A receptor antagonist Devazepide could reverse the antagonism of CCK-8 to the effect of morphine.CONCLUSION:CCK-8 could antagonize the effect of morphine which inhibited the potentiation of ACh on the duodenal activities in vitro.Furthermore, it was inferred that the antagonistic effect of CCK-8 on morphine was mainly mediated by CCK-A receptor.	Sincalide	139-144	cholecystokinin A receptor	Rattus norvegicus	27-41	
11819361-4	1998	On the basis of the above, CCK-A receptor antagonist Devazepide could reverse the antagonism of CCK-8 to the effect of morphine.CONCLUSION:CCK-8 could antagonize the effect of morphine which inhibited the potentiation of ACh on the duodenal activities in vitro.Furthermore, it was inferred that the antagonistic effect of CCK-8 on morphine was mainly mediated by CCK-A receptor.	Sincalide	139-144	cholecystokinin A receptor	Rattus norvegicus	363-377	
11819361-4	1998	On the basis of the above, CCK-A receptor antagonist Devazepide could reverse the antagonism of CCK-8 to the effect of morphine.CONCLUSION:CCK-8 could antagonize the effect of morphine which inhibited the potentiation of ACh on the duodenal activities in vitro.Furthermore, it was inferred that the antagonistic effect of CCK-8 on morphine was mainly mediated by CCK-A receptor.	Sincalide	139-144	cholecystokinin A receptor	Rattus norvegicus	27-41	
11819361-4	1998	On the basis of the above, CCK-A receptor antagonist Devazepide could reverse the antagonism of CCK-8 to the effect of morphine.CONCLUSION:CCK-8 could antagonize the effect of morphine which inhibited the potentiation of ACh on the duodenal activities in vitro.Furthermore, it was inferred that the antagonistic effect of CCK-8 on morphine was mainly mediated by CCK-A receptor.	Sincalide	139-144	cholecystokinin A receptor	Rattus norvegicus	363-377	
16297350-8	2005	This inhibitory effect of CCK-8 could be abrogated partly by proglumide (non-selective CCK receptor antagonist), CR-1409 (selective CCK-A receptor antagonist), and CR-2945 (selective CCK-B receptor antagonist) in a concentration-dependent manner (P< 0.01).	Sincalide	26-31	cholecystokinin A receptor	Rattus norvegicus	132-146	
8058194-6	1994	CCK-8-evoked cationic current was antagonized by lorglumide, a selective CCK-A receptor antagonist.	Sincalide	0-5	cholecystokinin A receptor	Rattus norvegicus	73-87